Search research articles
Contact Us
Filters
Showing results (571-580 of 713) with videos related to
Page
of 72
Sort By:
British Journal of Cancer
|
May 17, 2018
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers
Jorge Cortes, Kenji Tamura, Daniel J DeAngelo, et al.
Blood
|
June 29, 2007
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome
Andres O Soriano, Hui Yang, Stefan Faderl, et al.
The Lancet. Haematology
|
March 19, 2018
Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial
Maro Ohanian, Ana Tari Ashizawa, Guillermo Garcia-Manero, et al.
American Journal of Hematology
|
December 31, 2013
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy
Elias Jabbour, Naval Daver, Richard Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2010
Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia
Deborah A Thomas, Susan O'Brien, Stefan Faderl, et al.
The New England Journal of Medicine
|
June 16, 2006
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
Moshe Talpaz, Neil P Shah, Hagop Kantarjian, et al.
Blood
|
December 7, 2013
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
Elias Jabbour, Hagop M Kantarjian, Giuseppe Saglio, et al.
American Journal of Hematology
|
August 30, 2017
Clinical outcomes in adult patients with aplastic anemia: A single institution experience
Prajwal Boddu, Guillermo Garcia-Manero, Farhad Ravandi, et al.
Blood
|
May 20, 2006
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani, Giuseppe Saglio, John Goldman, et al.
Investigational New Drugs
|
April 22, 2008
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia
Wendy Stock, Samir D Undevia, Carol Bivins, et al.
Page
of 72
Search research articles
Search
Showing results (571-580 of 713) with videos related to
Sort By:
Page
of 72
British Journal of Cancer
|
May 17, 2018
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers
Jorge Cortes, Kenji Tamura, Daniel J DeAngelo, et al.
Blood
|
June 29, 2007
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome
Andres O Soriano, Hui Yang, Stefan Faderl, et al.
The Lancet. Haematology
|
March 19, 2018
Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial
Maro Ohanian, Ana Tari Ashizawa, Guillermo Garcia-Manero, et al.
American Journal of Hematology
|
December 31, 2013
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy
Elias Jabbour, Naval Daver, Richard Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2010
Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia
Deborah A Thomas, Susan O'Brien, Stefan Faderl, et al.
The New England Journal of Medicine
|
June 16, 2006
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
Moshe Talpaz, Neil P Shah, Hagop Kantarjian, et al.
Blood
|
December 7, 2013
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
Elias Jabbour, Hagop M Kantarjian, Giuseppe Saglio, et al.
American Journal of Hematology
|
August 30, 2017
Clinical outcomes in adult patients with aplastic anemia: A single institution experience
Prajwal Boddu, Guillermo Garcia-Manero, Farhad Ravandi, et al.
Blood
|
May 20, 2006
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani, Giuseppe Saglio, John Goldman, et al.
Investigational New Drugs
|
April 22, 2008
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia
Wendy Stock, Samir D Undevia, Carol Bivins, et al.
Page
of 72